1997•PubMedRequires access

New treatment options for psoriasis.

McClelland Pb

Abstract

Psoriasis is a chronic genetic disease characterized by hyperproliferation and inflammation of the epidermis and dermis. Presently there is no cure for psoriasis, only treatments to alleviate the symptoms. Tazarotene (Tazorac) is a new vitamin A derivative and the first topical retinoid to demonstrate therapeutic success in treating plaque-type psoriasis. This article will introduce you and your patients to the safe and effective use of tazarotene.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Tazarotene, Psoriasis, Medicine, Dermatology, Dermis, Retinoid, Pathology, Retinoic acid